Wren Therapeutics is based in Cambridge, UK. It has raised $45M in total funding. Backed by The Baupost Group, Schooner Capital, Industry Ventures.
Wren Therapeutics funding overview
Wren Therapeutics is based in Cambridge, UK. Wren Therapeutics has raised $45M in total disclosed funding. That places its disclosed total in the $25M–$100M range. The round record for Wren Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include The Baupost Group, Schooner Capital, Industry Ventures, LifeForce Capital. 4 distinct backers are named across the disclosed rounds.
Wren Therapeutics at a glance
Total raised
$45M
Latest round date
January 2021
Headquarters
Cambridge, UK
Notable investors
The Baupost Group, Schooner Capital, Industry Ventures, LifeForce Capital
Frequently asked about Wren Therapeutics funding
How much has Wren Therapeutics raised?
Wren Therapeutics has raised $45M in total disclosed funding across the rounds on record.
Who has invested in Wren Therapeutics?
The Baupost Group, Schooner Capital, Industry Ventures, LifeForce Capital are named among the investors backing Wren Therapeutics.
What was the latest Wren Therapeutics funding round?
No round stage has been disclosed for Wren Therapeutics.
Where is Wren Therapeutics based?
Wren Therapeutics is based in Cambridge, UK.
When did Wren Therapeutics last raise?
The last disclosed Wren Therapeutics round closed in January 2021.
We update the Wren Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Cambridge and their backers are listed below.
